Toufic Kachaamy,MD

MD

Interventional Program Specialist

Toufic Kachaamy - Medical Director of Interventional Gastroenterology (GI),  Endoscopy and Innovation, Gastroenterologist & Advanced Endoscopist
quotation

At CTCA, the multidisciplinary team approach is the norm, and not the exception. All the physicians and clinicians meet on a regular basis to discuss the best treatment plan for each patient.

Location
CTCA Phoenix
14200 West Celebrate Life Way
Goodyear, Arizona 85338
North Phoenix
2915 W. Rose Garden Lane
Phoenix, AZ 85027
Specialties
Gastroenterology
Education
Medical school:
American University of Beirut, Lebanon
Residency:
Internal Medicine – Duke University School of Medicine, Durham, NC
Fellowship:
Advanced Endoscopy – Mayo Clinic College of Medicine & Science, Phoenix, AZ
Gastroenterology – Virginia Commonwealth University, Richmond
Certifications
Gastroenterology - American Board of Internal Medicine

Dr. Toufic Kachaamy joined Cancer Treatment Centers of America® (CTCA), Phoenix, in July, 2013. As a gastroenterologist trained in advanced endoscopy, including endoscopic ultrasound, he helps care for patients fighting pancreatic, stomach, esophageal, colon, liver or bile duct cancer at our Phoenix hospital, where he serves as Chief of Medicine.

Dr. Kachaamy shares the same passion towards patient care that CTCA® embraces. “Here, the multidisciplinary team approach is the norm, and not the exception. All the physicians and clinicians meet on a regular basis to discuss the best treatment plan for each patient,” says Dr. Kachaamy, who also serves as Medical Director of Gastroenterology. “To me, the collaboration among providers is critical in providing whole-person care.”

Board certified by the American Board of Internal Medicine, Dr. Kachaamy earned a medical degree from the American University of Beirut in Lebanon. He then went on to complete an internship in internal medicine at Duke University in Durham, North Carolina. Additionally, he completed a fellowship in gastroenterology at Virginia Commonwealth University in Richmond Virginia. Dr. Kachaamy completed an advanced endoscopy fellowship at Mayo Clinic in Phoenix in 2012. He is also a member of Alpha Omega Alpha Honor Medical Society.

Dr. Kachaamy holds positions on a number of medical society boards, including as an Innovation Committee member with the American College of Gastroenterology and as Vice Chair of the Endoscopic Oncology Committee for the Foundation for Interventional & Therapeutic Endoscopy. He chairs of a national conference focused on innovation and endoscopic oncology, and is a member of the Medical Advisory Board for the Colon Cancer Coalition.

Dr. Kachaamy is a clinical researcher in the fields of cancer quality-of-life outcomes and cancer ablation, including cryotherapy. His research has been published in Gastrointestinal Endoscopy, expert reviews of Gastroenterology and Hepatology, and Clinical Gastroenterology and Hepatology and Current Opinion in Gastroenterology. He has also given many research and oral presentations in national meetings on topics related to digestive health. An innovator and pioneer, he invented a simple device called the Sure Access Needle, which helps doctors access the bile duct during an endoscopic retrograde cholangiopancreatography (ERCP), one of the biggest challenges to a successful ERCP. The device won the 2021 AGA Shark Tank contest hosted by the American Gastroenterological Association. 

Dr. Kachaamy believes in one objective: Providing the best possible care to the patient in a compassionate way. “I tell my patients, if it can be done, we will do it.”

In his spare time, Dr. Kachaamy enjoys traveling, learning about new cultures, cooking and skiing. He also enjoys spending time with his wife and three sons, and was recently recognized as one of Phoenix's favorite dads.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.